Document Detail

Not all sarcomas developed in irradiated tissue are necessarily radiation-induced - Spectrum of disease and treatment characteristics.
MedLine Citation:
PMID:  22138059     Owner:  NLM     Status:  Publisher    
BACKGROUND: Sarcomas in irradiated tissue (SITs) are often considered with second cancers, although they usually present distinct dose-response, genetic and clinical patterns. The contribution of radiation in SIT development is likely, but remains unproven in many cases. MATERIALS AND METHODS: We reviewed the literature for published data on SITs. RESULTS: SITs incidence ranged between 0.03% and 0.2%. Median latency was 15years. Angiosarcoma was the second most common subtype after undifferentiated sarcomas of malignant fibrous histiocytoma (MFH). C-Myc overexpression can be used to identify radiation-induced angiosarcoma, and a recently described transcriptomic signature of genes involved in chronic oxidative stress and mitochondrial dysfunction may indicate radiation causality. Osteosarcomas were often associated with genetic predisposition. Five-year survival rates rarely exceeded 30% because the therapeutic possibilities were often limited by the first cancer. Chemotherapy response may differ from that of de novo sarcomas. CONCLUSION: SITs present different characteristics from non-sarcomatoid second cancers. Reporting of SIT cases and the establishment of tissue and serum banks is necessary to better understand and validate the recently discovered radiation signature.
Juliette Thariat; Antoine Italiano; Fabrice Collin; Antoine Iannessi; Pierre-Yves Marcy; Alexis Lacout; Isabelle Birtwisle-Peyrottes; Antoine Thyss; Jean-Léon Lagrange
Related Documents :
22105249 - Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic...
21871419 - Inpatient rehabilitation of patients with cancer: efficacy and treatment considerations.
22242939 - Cancer somatic mutations disrupt functions of the epha3 receptor tyrosine kinase throug...
22059859 - A rare case of recurrent ovarian cancer presenting as a round ligament metastasis.
21873169 - Decreased expression of claudin-1 in rectal cancer: a factor for recurrence and poor pr...
21708849 - The second step of the analgesic ladder and oral tramadol in the treatment of mild to m...
25328419 - Quality of venous thromboembolism diagnoses among prostate cancer patients in the danis...
11171429 - Workshop report: physical activity and cancer prevention.
12527919 - Egfr family signaling and its association with breast cancer development and resistance...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-2
Journal Detail:
Title:  Critical reviews in oncology/hematology     Volume:  -     ISSN:  1879-0461     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8916049     Medline TA:  Crit Rev Oncol Hematol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Department of Radiation Oncology/IBDC CNRS UMR 6543 Institut Universitaire de la Face et du Cou, Antoine-Lacassagne Cancer Center, Nice Sophia-Antipolis University, 33 Av. Valombrose, 06189 Nice Cedex 2, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Ultrasonographic Lung Sliding Sign in Confirming Proper Endotracheal Intubation during Emergency Int...
Next Document:  Review: Human trophoblast fusion and differentiation: Lessons from trisomy 21 placenta.